Stay updated on High-Dose Flu Vaccine in Young Children Clinical Trial

Sign up to get notified when there's something new on the High-Dose Flu Vaccine in Young Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High-Dose Flu Vaccine in Young Children Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record related to the comparison of high-dose quadrivalent influenza vaccine (QIV-HD) to standard-dose quadrivalent influenza vaccine (QIV-SD) in children aged 6 months through 35 months for the prevention of laboratory-confirmed influenza illness caused by any influenza A or B type.
    Difference
    0.1%
    Check dated 2024-06-06T14:50:24.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age range, consent requirements, and other health-related conditions. Previously, this section had no information provided.
    Difference
    30%
    Check dated 2024-05-22T21:31:00.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:27:53.000Z thumbnail image

Stay in the know with updates to High-Dose Flu Vaccine in Young Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High-Dose Flu Vaccine in Young Children Clinical Trial page.